Schott Pharma Stock - analyst views and long-term positioning
Published on 06/20/2026 at 15:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Edited by ad hoc news Long-Term & Business-Model Desk. Verified prior to publication on 06/20/2026, 15:51 CET. Details in the imprint.
Schott Pharma (DE000A3ENQ51) continues to attract attention from healthcare-focused investors on the German market. With no new ad-hoc announcements or major analyst rating changes reported today, the spotlight falls on the company’s existing consensus, SDAX role, and long-term business model.
Key data and news on Schott Pharma stock
All recent headlines, background reports, and market data on Schott Pharma stock can be found in the ad-hoc-news topic overview and on the company’s investor relations page.
What analysts and the market say
Schott Pharma AG & Co. KGaA returned to the public market in 2023 and is currently traded in the SDAX, making it part of the smaller-cap German equity universe in healthcare-related equipment.
According to current data from German market portals, the stock is covered by several broker houses, with a mixed but generally constructive view on the long-term growth case.
Long-term positioning and moat
The long-term investment narrative centers on injectable drugs and complex biologics, for which Schott Pharma supplies high-value primary packaging and drug delivery components.
Management has repeatedly emphasized in public presentations that structural growth in biologics, vaccines, and specialty medicines supports demand for high-quality containment solutions over many years, independent of short-term macro volatility.
How the company makes money
Schott Pharma generates most of its revenue by developing and manufacturing glass and polymer primary packaging systems for injectable drugs, including prefillable syringes, vials, and cartridges used by pharmaceutical and biotech companies worldwide.
Where the stock trades today
The shares of Schott Pharma (DE000A3ENQ51) trade on Xetra in Frankfurt; the latest available quote from German market data shows the stock changing hands in euros during regular CET trading hours.
Key facts on Schott Pharma stock
- Company: SCHOTT Pharma AG & Co. KGaA
- ISIN: DE000A3ENQ51
- WKN: A3ENQ5
- Ticker: 1SXP
- Venue: Xetra
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
